scholarly journals Virtual navigation with 3D-CT volume rendering and virtual endoscopy as a helpful tool for percutaneous endoscopic gastrostomy (PEG) placement in an advanced esophageal cancer patient

2012 ◽  
Vol 80 (2) ◽  
pp. 78-79
Author(s):  
Kohei Tanaka ◽  
Ryoko Kataoka ◽  
Hiroaki Makiyama ◽  
Atsushi Nakamura ◽  
Rikiya Fujita
Keyword(s):  
Esophageal Cancer ◽  
Volume Rendering ◽  
Virtual Endoscopy ◽  
Esophageal Cancer Patient ◽  
3D Ct ◽  
Advanced Esophageal Cancer ◽  
Virtual Navigation ◽  
Helpful Tool ◽  
Endoscopic Gastrostomy ◽  
Ct Volume

scholarly journals Single minimum incision endoscopic radical nephrectomy for renal tumors with preoperative virtual navigation using 3D-CT volume-rendering

BMC Urology ◽  
2010 ◽  
Vol 10 (1) ◽  
Author(s):  
Takao Kamai ◽  
Nobutaka Furuya ◽  
Tsunehito Kambara ◽  
Hideyuki Abe ◽  
Mikihiko Honda ◽  
...  
Keyword(s):  
Volume Rendering ◽  
Radical Nephrectomy ◽  
Renal Tumors ◽  
3D Ct ◽  
Virtual Navigation ◽  
Ct Volume

scholarly journals Investigative therapy for advanced esophageal cancer using the option for combined immunotherapy and chemotherapy

Immunotherapy ◽  
2020 ◽  
Author(s):  
Huan Wang ◽  
Tian-Tian Xuan ◽  
Ying Chen ◽  
Hui Yu ◽  
Tian-Tian Gu ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Stage Iv ◽  
Esophageal Cancer Patient ◽  
Line Treatment ◽  
Advanced Esophageal Cancer ◽  
First Line ◽  
Combined Immunotherapy ◽  
First Line Treatment

Aim: Advanced esophageal cancer has limited therapeutic options and a poor outcome. The efficacy of immunotherapy, as the first-line treatment of advanced esophageal cancer, is uncertain. Results: A stage IV advanced esophageal cancer patient received the first-line treatment with a combination of pembrolizumab and chemotherapy. Partial response (PR) was achieved after three cycles, and the efficacy was evaluated as stable after six cycles of immunochemotherapy and two cycles of maintenance monotherapy. Immune-related adverse events (irAEs) were not obvious. The patient was followed up till November 2019 when he died of gastrointestinal hemorrhage. Conclusion: The combination of an immune checkpoint inhibitor and chemotherapy is effective and safe for the initial treatment of advanced esophageal cancer. To confirm the evidence from this case, larger clinical trials are required in the future.

Comparison of Introducer Percutaneous Endoscopic Gastrostomy with Open Gastrostomy in Advanced Esophageal Cancer Patients

Dysphagia ◽  
2019 ◽  
Vol 35 (1) ◽  
pp. 117-120 ◽  
Author(s):  
Prasit Mahawongkajit ◽  
Ajjana Techagumpuch ◽  
Palin Limpavitayaporn ◽  
Amonpon Kanlerd ◽  
Ekkapak Sriussadaporn ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Advanced Esophageal Cancer ◽  
Endoscopic Gastrostomy

scholarly journals Usefulness of Percutaneous Transesophageal Gastro-Tubing in Patients Receiving Chemoradiotherapy for Advanced Esophageal Cancer: A Case Report

2019 ◽  
Vol 12 (3) ◽  
pp. 901-908 ◽  
Author(s):  
Atsushi Naganuma ◽  
Ayaka Kishi ◽  
Yusuke Ogawa ◽  
Tomohiro Kudo ◽  
Yoshizumi Kitamoto ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Nasogastric Tube ◽  
Feeding Tube ◽  
Radiation Dermatitis ◽  
Nutritional Management ◽  
Advanced Esophageal Cancer ◽  
Enteral Feeding Tube ◽  
Endoscopic Gastrostomy ◽  
Irradiation Field ◽  
Patients At Risk

Percutaneous endoscopic gastrostomy (PEG) is often performed for nutritional management in advanced esophageal cancer. We here report a patient who initially received enteral nutrition via a nasogastric tube and in whom the subsequent use of percutaneous transesophageal gastro-tubing (PTEG) circumvented the need for a gastrostomy. It is believed that PEG is less painful than a nasogastric tube. However, we selected PTEG because a PEG would have been within the planned irradiation field and there was concern about radiation dermatitis. We were able to administer chemoradiotherapy with sufficient nutrition via an enteral feeding tube via esophagostomy. PTEG is a very useful tool in patients at risk of radiation dermatitis of the abdomen.

scholarly journals Percutaneous endoscopic gastrostomy for nutritional palliation of upper esophageal cancer unsuitable for esophageal stenting

2012 ◽  
Vol 49 (3) ◽  
pp. 227-231 ◽  
Author(s):  
Ana Grilo ◽  
Carla Adriana Santos ◽  
Jorge Fonseca
Keyword(s):  
Body Mass Index ◽  
Esophageal Cancer ◽  
Body Mass ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Nutritional Support ◽  
Oral Intake ◽  
Upper Esophageal Sphincter ◽  
Advanced Esophageal Cancer ◽  
Endoscopic Gastrostomy ◽  
Esophageal Stenting

CONTEXT: Esophageal cancer is often diagnosed at an advanced stage and has a poor prognosis. Most patients with advanced esophageal cancer have significant dysphagia that contributes to weight loss and malnutrition. Esophageal stenting is a widespread palliation approach, but unsuitable for cancers near the upper esophageal sphincter, were stents are poorly tolerated. Generally, guidelines do not support endoscopic gastrostomy in this clinical setting, but it may be the best option for nutritional support. OBJECTIVE: Retrospective evaluation of patients with dysphagia caused advanced esophageal cancer, no expectation of resuming oral intake and with percutaneous endoscopic gastrostomy for comfort palliative nutrition. METHOD: We selected adult patients with unresecable esophageal cancer histological confirmed, in whom stenting was impossible due to proximal location, and chemotherapy or radiotherapy were palliative, using gastrostomy for enteral nutrition. Clinical and nutritional data were evaluated, including success of gastrostomy, procedure complications and survival after percutaneous endoscopic gastrostomy, and evolution of body mass index, albumin, transferrin and cholesterol. RESULTS: Seventeen males with stage III or IV squamous cell carcinoma fulfilled the inclusion criteria. Mean age was 60.9 years. Most of the patients had toxic habits. All underwent palliative chemotherapy or radiotherapy. Gastrostomy was successfully performed in all, but nine required prior dilatation. Most had the gastrostomy within 2 months after diagnosis. There was a buried bumper syndrome treated with tube replacement and four minor complications. There were no cases of implantation metastases or procedure related mortality. Two patients were lost and 12 died. Mean survival of deceased patients was 5.9 months. Three patients are alive 6, 14 and 17 months after the gastrostomy procedure, still increasing the mean survival. Mean body mass index and laboratory parameters were roughly stable 1 and 3 months after the gastrostomy procedure. CONCLUSIONS: In patients with advanced upper esophageal cancer where only palliative treatment is possible, nutritional support is easily achieved with percutaneous endoscopic gastrostomy, allowing patients to be at homes, surviving a significant period of time. Percutaneous endoscopic gastrostomy feeding should be considered as standard definitive nutritional palliation in patients with upper esophageal cancer, unsuitable for esophageal stenting.

scholarly journals 3D-CT imaging processing for qualitative and quantitative analysis of maxillofacial cysts and tumors

2002 ◽  
Vol 16 (3) ◽  
pp. 189-194 ◽  
Author(s):  
Marcelo de Gusmão Paraiso Cavalcanti ◽  
José Leopoldo Ferreira Antunes
Keyword(s):  
Volume Rendering ◽  
3D Ct ◽  
Qualitative And Quantitative ◽  
Surface Method ◽  
3D Volume ◽  
Accurate Observation ◽  
3D Volume Rendering ◽  
Surface Technique ◽  
Ct Volume ◽  
Volume Rendering Technique

The objective of this study was to evaluate spiral-computed tomography (3D-CT) images of 20 patients presenting with cysts and tumors in the maxillofacial complex, in order to compare the surface and volume techniques of image rendering. The qualitative and quantitative appraisal indicated that the volume technique allowed a more precise and accurate observation than the surface method. On the average, the measurements obtained by means of the 3D volume-rendering technique were 6.28% higher than those obtained by means of the surface method. The sensitivity of the 3D surface technique was lower than that of the 3D volume technique for all conditions stipulated in the diagnosis and evaluation of lesions. We concluded that the 3D-CT volume rendering technique was more reproducible and sensitive than the 3D-CT surface method, in the diagnosis, treatment planning and evaluation of maxillofacial lesions, especially those with intra-osseous involvement.

PS02.134: COMPARISON OF PUSH PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH OPEN GASTROSTOMY IN ADVANCED ESOPHAGEAL CANCER PATIENTS

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 159-159
Author(s):  
Prasit Mahawongkajit
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Conflicts Of Interest ◽  
Invasive Procedure ◽  
Feeding Tube ◽  
Treatment Quality ◽  
Advanced Esophageal Cancer ◽  
Endoscopic Gastrostomy ◽  
Improve Patient

Abstract Background In esophageal cancer treatment, nutrition by feeding tube has been demonstrated to improve patient tolerance of treatment, quality of life, and long term outcomes. The open gastrostomy and percutaneous endoscopic gastrostomy (PEG) push technique are procedures that avoid cancer cells seeding and also improve patient nutritional status. The aim of this study is to compare the results of the push PEG and open gastrostomy in patients with advanced esophageal cancer. Methods A retrospective study was analyzed in the advanced esophageal cancer patients who indicated and received feeding support between January 2016 and December 2017. Results 28 patients in push PEG and 36 patients in open gastrostomy presented the following comparative data: mean operative duration time shorter in push PEG (11.9 min) than open gastrostomy (35.1 min), less blood loss in push PEG (0.8 mL) than open gastrostomy (5.6 mL), less pain score in push PEG (2.4) than open gastrostomy (5.9) and shorter hospitalization in push PEG (1.8 days) than open gastrostomy (2.6 days). Both groups showed no readmission or 30 day mortality. The adverse events of open gastrostomy demonstrated higher than push PEG group. Conclusion Both push PEG and open gastrostomy were the safe options for advanced esophageal cancer patients indicating for enteral nutrition and to avoid cancer cell seeding. The push PEG demonstrated the effective minimally invasive procedure, was safe and with fewer complications. Disclosure All authors have declared no conflicts of interest.

Sign in / Sign up

Export Citation Format

Share Document